Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression

By  

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine receptor binding in major depression: changes before and after treatment with selective serotonin reuptake inhibitors

By Klimke A.   Larisch R.   Janz A.   Vosberg H.   Muuml ller-Gauml rtner H.W.   Gaebel W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-300

Elsevier

Access to resources Recommend Favorite

Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a ¹²³I-ADAM SPECT study

By Catafau Ana   Perez Victor   Plaza Pedro   Pascual Juan-Carlos   Bullich Santiago   Suarez Marina   Penengo Maria   Corripio Iluminada   Puigdemont Dolors   Danus Monica   Perich Javier   Alvarez Enric  

Psychopharmacology, Vol. 189, Iss. 2, 2006-12 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse

By Weizman Abraham   Weizman Ronit  

Pharmacogenomics, Vol. 1, Iss. 3, 2000-08 ,pp. : 335-341

Future Medicine

Access to resources Recommend Favorite

Brain-derived Neurotrophic Factor Genetic Variants are Associated with Major Depression Susceptibility and Serotonin Reuptake Inhibitor Antidepressant Treatment Response in Taiwanese

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 4, 2013-12 ,pp. : 316-323

Bentham Science Publishers

Access to resources Recommend Favorite